Pancreatic ductal adenocarcinoma (PDAC) remains one of the most formidable challenges in oncology, persistently defying decades of therapeutic innovation and...

The intricate relationship between aging and cancer has long perplexed scientists and clinicians alike. While cancer is predominantly recognized as...

The landscape of non-small cell lung cancer (NSCLC) treatment has undergone a radical transformation in recent years, driven by advances...

In a significant advancement for the treatment of advanced cutaneous squamous cell carcinoma (cSCC), a phase II clinical trial spearheaded...

In a significant advancement in the treatment of advanced cutaneous squamous cell carcinoma (cSCC), a randomized phase II clinical trial...

The landscape of anal squamous cell carcinoma (ASCC), a rare yet increasingly prevalent malignancy, is undergoing a profound transformation fueled...

In the relentless quest to harness the immune system’s power to combat cancer, researchers are increasingly turning their attention to...

The relentless challenge posed by glioblastoma multiforme (GBM), the most aggressive and lethal primary brain tumor, continues to galvanize oncological...

Immune checkpoint inhibitors (ICIs) have rapidly transformed the landscape of oncology by harnessing the body's immune system to combat malignancies....

The landscape of non-small-cell lung cancer (NSCLC) treatment is transforming at an unprecedented pace, shaped profoundly by the integration of...